These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 27556178)
21. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M Clin Oncol (R Coll Radiol); 2005 May; 17(3):148-52. PubMed ID: 15900997 [TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526 [TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial. Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ; Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376 [TBL] [Abstract][Full Text] [Related]
24. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415 [TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158 [TBL] [Abstract][Full Text] [Related]
26. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients. Fayette J; Bonnin N; Ferlay C; Lallemant B; Ramade A; Favrel V; Zrounba P; Chabaud S; Pommier P; Poupart M; Céruse P Anticancer Drugs; 2013 Jul; 24(6):623-9. PubMed ID: 23542750 [TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150 [TBL] [Abstract][Full Text] [Related]
30. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients. Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis. Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462 [TBL] [Abstract][Full Text] [Related]
32. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes. Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058 [TBL] [Abstract][Full Text] [Related]
33. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552 [TBL] [Abstract][Full Text] [Related]
34. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer. Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151 [TBL] [Abstract][Full Text] [Related]
35. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632 [TBL] [Abstract][Full Text] [Related]
36. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Paccagnella A; Ghi MG; Loreggian L; Buffoli A; Koussis H; Mione CA; Bonetti A; Campostrini F; Gardani G; Ardizzoia A; Dondi D; Guaraldi M; Cavallo R; Tomio L; Gava A; Ann Oncol; 2010 Jul; 21(7):1515-1522. PubMed ID: 20032123 [TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
38. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents. Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059 [TBL] [Abstract][Full Text] [Related]
39. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension]. Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002 [TBL] [Abstract][Full Text] [Related]
40. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]